Hill Research

Hill Research, based in the US, specializes in AI-driven solutions for the clinical data workflow in pharmaceutical research, enhancing accuracy and compliance through advanced automation and statistical programming. Hill Research is dedicated to transforming clinical research workflows with AI technologies. The company was founded in Princeton, US, and has engaged in a significant funding round on December 10, 2025, raising USD 1. 75 mn from investors including Covenant Venture Capital and the New Jersey Economic Development Authority.

Since its inception, Hill Research has pursued innovations in clinical data management to support pharmaceutical companies in streamlining their processes. Hill Research primarily offers AI-powered solutions aimed at transforming the clinical data workflow in pharmaceutical and clinical research settings. Their core offerings include advanced statistical programming, AI-assisted quality assurance, and end-to-end automation of clinical data processes, which enhance data accuracy and regulatory compliance. The flagship product, TriClick™, is a comprehensive platform that automates tasks such as CDISC mapping, TLF generation, and annotation, aiming to drastically reduce the manual workload by 60-70%.

Hill Research serves a diverse client base of over 10 global pharmaceutical companies, including two of the top three and five of the top ten, providing solutions to enhance their clinical trial efficiency, from protocol design to FDA submission. Their products are utilized across various geographical markets, including North America, Europe, and Asia, addressing the growing need for faster, more reliable clinical trial processes that support the development of life-saving treatments. The revenue model for Hill Research is structured around offering B2B services to pharmaceutical companies, where clients engage with the company for specialized statistical programming and automation solutions. Transactions are conducted through project-based agreements, subscriptions for ongoing support, and customized service offerings, such as Functional Service Provider (FSP) solutions that integrate scalable programming teams into the client’s workflows.

Clients may enter contracts for specific projects, which include comprehensive packages that comprise TriClick™ services and other AI-driven solutions tailored to meet regulatory requirements. The pricing structure reflects the advanced capabilities provided by their technology, aiming to deliver significant cost savings and efficiency improvements for their clients in the pharmaceutical sector. In December 2025, Hill Research raised USD 1. 75 mn in venture funding, which will support the development of new AI products focused on enhancing clinical data workflows.

The company aims to expand into European and Asian markets by mid-2026, targeting partnerships with additional pharmaceutical firms to leverage their advanced technology solutions. This funding will enable the company to enhance their product offerings and facilitate entry into these new regions.